Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
Study NCT ID:
NCT00389051
Status:
COMPLETED
Last Update Posted:
2020-10-22
First Post:
2006-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma
Sponsor:
SymBio Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2006001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Katsuhisa Goto
Old Organization:
SymBio Pharmaceuticals Limited